Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sharon Barber-Lui Insider Profile
4 Followers
Sharon Barber-Lui, Director at PureTech Health, holds ― shares in PureTech Health (Ticker: GB:PRTC).
Sharon Barber-Lui has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Sharon Barber-Lui does not currently own shares as a corporate insider.
A breakdown of Sharon Barber-Lui's holdings
Insider Roles
Director
Roles that Sharon Barber-Lui holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Sharon Barber-Lui
Sharon Barber-Lui's Trading History
List of latest transactions for each holding click on a transaction to see Sharon Barber-Lui's performance on stock
You May Also Like
Sharon Barber-Lui insider profile FAQ
What is the percentage of profitable transactions made by Sharon Barber-Lui?
The percentage of profitable transactions made by Sharon Barber-Lui is ―.
What is the average return per transaction made by Sharon Barber-Lui?
The average return per transaction made by Sharon Barber-Lui is ―.
What stocks does Sharon Barber-Lui hold?
Sharon Barber-Lui holds: GB:PRTC stocks.
What was Sharon Barber-Lui’s latest transaction?
Sharon Barber-Lui latest transaction was an Uninformative Buy of ―.
What was Sharon Barber-Lui's most profitable transaction?
Sharon Barber-Lui’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Sharon Barber-Lui's role in PureTech Health?
Sharon Barber-Lui's role in PureTech Health is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.